Page 77 - Predicting survival in patients with spinal bone metastasesL
P. 77
months (95%CI 2.0-20.0) in the triple negative category and 21.1 months (95%CI 14.0-28.2) in the receptor positive category (p=0.005).
Figure 1A. Survival curves of all four phenotypes
Figure 1B. Survival curves after merging
V
BREAST CANCER
75
